Harvoni ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
254Porphyria1

254. Porphyria


Clinical trials : 70 Drugs : 54 - (DrugBank : 19) / Drug target genes : 19 - Drug target pathways : 35
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03118674
(ClinicalTrials.gov)
September 6, 201713/4/2017Harvoni Treatment Porphyria Cutanea TardaNewer Direct-Acting Anti-Viral Agents as Sole Therapy of Porphyria Cutanea Tarda in Subjects With Chronic Hepatitis CPorphyria Cutanea Tarda;Hepatitis CDrug: HarvoniWake Forest University Health SciencesGilead Sciences;National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);National Institutes of Health (NIH)Active, not recruiting18 YearsN/AAll25Phase 2United States